Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer

Korean Journal of Urology

Volumn 53, Issue 5, 2012, Pages 371-374

  Min, Byung Dal ^a   Kang, Ho Won ^a   Kim, Won Tae ^a   Kim, Yong June ^a   Yun, Seok Joong ^a   Lee, Sang Cheol ^a   Kim, Wun Jae ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

Docetaxel; Interstitial pneumonitis; Prostatic neoplasms

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; DOCETAXEL; DOPAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; VANCOMYCIN;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BONE METASTASIS; CASE REPORT; CASTRATION RESISTANT PROSTATE CANCER; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DEATH; DISEASE SEVERITY; DOCETAXEL INDUCED FATAL INTERSTITIAL PNEUMONITIS; DRUG INDUCED DISEASE; DYSPNEA; FATALITY; FEVER; HUMAN; HYPERSENSITIVITY; HYPOTENSION; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; INTUBATION; LEUKOPENIA; LUNG LAVAGE; LUNG TOXICITY; MALE; MULTIPLE CYCLE TREATMENT; RESUSCITATION; SPUTUM; SPUTUM CULTURE; THORAX RADIOGRAPHY;

EID: 84861893105     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2012.53.5.371     Document Type: Article

References (10)

1. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351:1502-1512.
2. Fossella FV. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials. Semin Oncol 1999;26(5 Suppl 16):17-23.
3. Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res 1997;57:229-233.
4. Kunitoh H, Watanabe K, Onoshi T, Furuse K, Niitani H, Taguchi T. Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. J Clin Oncol 1996;14:1649-1655.
5. Choy H, Safran H, Akerley W, Graziano SL, Bogart JA, Cole BF. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clin Cancer Res 1998;4:1931-1936.
6. Wang GS, Yang KY, Perng RP. Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere). Br J Cancer 2001;85:1247-1250.
7. Read WL, Mortimer JE, Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer 2002;94: 847-853.
8. Leimgruber K, Negro R, Baier S, Moser B, Resch G, Sansone S, et al. Fatal interstitial pneumonitis associated with docetaxel ad- ministration in a patient with hormone-refractory prostate cancer. Tumori 2006;92:542-544.
9. Grande C, Villanueva MJ, Huidobro G, Casal J. Docetaxel-in-duced interstitial pneumonitis following non-small-cell lung can-cer treatment. Clin Transl Oncol 2007;9:578-581.
10. Nagata S, Ueda N, Yoshida Y, Matsuda H, Maehara Y. Severe interstitial pneumonitis associated with the administration of taxanes. J Infect Chemother 2010;16:340-344.